Moderna stock rises 2% on Nasdaq 100 entry but this analyst says sell
Moderna stock (NASDAQ: MRNA) rose more than 2% in early premarket trading on Friday after Nasdaq said the biotech company will join the Nasdaq-100 next week, creating new demand from…